Upload
dinhmien
View
215
Download
2
Embed Size (px)
Citation preview
1
2015 IWF Anti-Doping
Program and related
legal matters
16th December 2015
EWF Scientific Seminar
Rome, ITA
Dr. Magdolna Trombitás
IWF Legal counsel
IWF ANTI-DOPING STRATEGY
• Test Distribution Plan was elaborated inJanuary – several criteria, basic decisionsbut it changes constantly
• WHO (Which athlete?)
• WHEN (IC/OOC)
• WITH WHO (Which ADO?)
• LABORATORY
Quality vs. Quantity
2
SELECTION OF THE ATHLETE
Some examples
- Intelligence
- Results
- History (missed tests/filing failures,
doping)
- Federation’s history
- Coach or entourage
3
Who are the International
Level Athletes?
● Athletes who are part of the IWF Registered
Testing Pool;
● Athletes who participate in IWF Events.
● Such Athletes are already considered as
International-Level Athletes during the two-
month period prior to the IWF Event in
question.
IT IS THE NATIONAL FEDERATIONS’
RESPONSIBILITY TO INFORM THE ATHLETES
ABOUT THEIR WHEREABOUTS OBLIGATIONS
!
IWF Registered Testing Pool (IRTP) – Provide
whereabouts quarterly for the whole year
Athletes who participate in IWF Events – Provide
whereabouts 2 months before and during the IWF
Event
Whereabouts via
In cae of any questions please write to
What did 2015 bring to us?
1. Complex, structured Policy
2. Global fight and increased communication
with the Anti-Doping Community
3. Various legal challenges
4. Increased testing and analytical
requirements
6
What did 2015 bring to us?
1. Complex, structured Code & Policy
Sport specific IRTP
Fixed Pool
Moving Pool (2 months rule)
New Anti-Doping Rule violations
Increased monitoring of the ENTOURAGE
Prohibited association
Strenghten the clear and neutral structure of the
decision making bodies
ADC, Hearing Panel, TUE Panel
Faster RM procedures – due to the public disclosure
guidelines 7
What did 2015 bring to us?
2. Global fight and increased communication
with the Anti-Doping Community
NADOs, RADOs, WADA
Testing plans
Intelligence
Investigation - INTERPOL
Data sharing
IF – NADO Working Group
8
What did 2015 bring to us?
3. Various legal challenges
Testing
Respective rights and responsabilities – WADA Code
Data sharing
Result management
Contaminated supplements
Contaminated meat
Negligence of the Federations/Athletes!
New articles – practice - Reductions
Whereabouts failures
9
What did 2015 bring to us?
Whereabouts failures:
WADA missions – 1/3 UNSUCCESSFUL
Definitions- exact definition in Article 3.2 of the ISTI
Missed test: a failure by the Athlete to be available for Testing at the
location and time specified in the 60-minute time slot identified in his/her
Whereabouts Filing for the day in question
Filing Failure: a failure to make an accurate and complete Whereabouts Filing
or failure to keep the provided whereabouts information accurate
Whereabouts failures can aggravate to an Anti-Doping rule
violation pursuant to Article 2.4 of the IWF Anti-Doping
Policy:
Any combination of three missed tests and/or filing failures within a twelve
month period constitutes an Anti-Doping rule violation.
What did 2015 bring to us?
4. Increased testing and analytical
requirements
TDSSA – WADA Technical Document for
Sport Specific Analysis
30% - hGH / GHRS
5% - ESAs
APMU - Cologne
Recommendations shall be followed up
automatically
11
What did 2015 bring to us?
STEROID PROFILE
Athletes biomarkers
- Shows also the effect of doping
- APMU recommendations – further analysis,
- Long term storage – 10 years
- Target testing
12
13
Statistics on the doping controls
2015
Number of tests
IC OOC Total
Men 609 304 913
Women 456 212 668
Total 1065 516 1581
14
0
100
200
300
400
500
600
Athletes Tested by Continents*up to Houston WWC
15
• ALG • CRO • GUA • KOR • PAR • SYR
• ARG • CUB • HON • KSA • PER • THA
• ARM • CYP • HUN • LAT • PHI • TJK
• ARU • CZE • INA • LBA • PNG • TKM
• AUS • DEN • IND • LTU • POL • TPE
• AUT • DOM • IRI • MAD • PRK • TUN
• AZE • ECU • IRL • MAR • PUR • TUR
• BAN • EGY • IRQ • MAS • QAT • UAE
• BLR • ESA • ISL • MDA • ROU • UGA
• BRA • ESP • ISR • MEX • RSA • UKR
• BUL • FIJ • ITA • MRI • RUS • USA
• CAN • FIN • JOR • NCA • SAM • UZB
• CHI • FRA • JPN • NOR • SEY • VEN
• CHN • GBR • KAZ • NRU • SOL • VIE
• CMR • GEO • KEN • NZL • SRI
• COL • GER • KGZ • PAK • SVK
• CRC • GRE • KIR • PAN • SWE
Countries tested*up to Houston WWC
16
0 100 200 300 400
Africa
America
Asia
Europe
Oceania
OOC
IC
IC / OOC by Continents*up to Houston WWC
Substances in 2015
17
BOLDENONE
CLENBUTEROL
DEHYDROCHLOROMETHYLTESTOSTERONE
D-METHAMPHETAMINE
FUROSEMIDE
HYDROCHLOROTHIAZIDE
METHANDIENONE
METHANDRIOL
METHASTERONE
METHENOLONE
METHYLTESTOSTERONE
NANDROLONE
OXANDROLONE
STANOZOLOL
TRENBOLONE
18
Ameloride Etiocholanlone Oxilofrine
Androsteneolone Furosemide Pregnanediol
Androsterone Hydrochlorothiazide Stanozolol
Boldenone Hydroxystanozolol Tamoxifen
Cannabinoids
Metenolone Testosterone/Epitestostero
ne>4
Cannabis Methadone
Canrenone Methandienone
Clenbuterol Methandriol
Clomiphene Methylhexaneamine
Clostebol
Methylphenidate
Cocaine Methyltandrosterone
Dehydrochloromethyltestost
erone
Methyltestosterone
Dehydromethyltestosterone Morphine
DHEA Nandrolone
Dimethylpentylamine Norandrosterone
Drostanolone
Oxandrolone
Substances in 2011-2014
Report on AAFs
60 Adverse Analytical Findings
- More than 30 are closed as an ANTI-DOPING
RULE VIOLATIONS or as a no violation
- 5 Hearings were held in the Houston Session –
21 days
- 7 cases from the WWC so far
Multiple AAFs during the Pre-testing
OOCs for the 2015 WWC
Public disclosures
PUBLIC
DISCLOSURE
RETIREMENT RULES
● „NORMAL ”RETIREMENT – 6 MONTHS
RULE
● RETIREMENT DURING RESULT
MANAGEMENT
● RETIREMENT DURING INELIGIBILITY
RETIREMENT RULES
START of suspensio
n
Start of retirement
REINSTATEMENT
Time of suspension
passes
Time of suspension
does not pass
A new prohibited substance called
MILDRONATE (Meldonium) which
was in the WADA Monitoring Program
in 2015 and will be prohibited from
the 1st January 2016.
The most used trade names for the substance are:
mildronate, meldonium, Quaterin, Kvaretin, THP.
According to recent scientific publications of the
WADA accredited laboratories Cologne and
Moscow, 2-17 % of doping control samples collected
in 2014 and 2015 contained mildronate.